Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA), a clinical-stage medical dermatology and aesthetics company, today announced that two pivotal acne trials with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE